DE602004022139D1 - - Google Patents

Info

Publication number
DE602004022139D1
DE602004022139D1 DE602004022139T DE602004022139T DE602004022139D1 DE 602004022139 D1 DE602004022139 D1 DE 602004022139D1 DE 602004022139 T DE602004022139 T DE 602004022139T DE 602004022139 T DE602004022139 T DE 602004022139T DE 602004022139 D1 DE602004022139 D1 DE 602004022139D1
Authority
DE
Germany
Prior art keywords
fish
vaccine
vnn
inactivating
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004022139T
Other languages
English (en)
Inventor
Santos Nuno Dos
Jacqueline Ireland
Andrew Cartner Barnes
Michael Horne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Pharma GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32910468&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004022139(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0303867A external-priority patent/GB0303867D0/en
Priority claimed from GB0320195A external-priority patent/GB0320195D0/en
Application filed by Novartis Pharma GmbH, Novartis AG filed Critical Novartis Pharma GmbH
Publication of DE602004022139D1 publication Critical patent/DE602004022139D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30061—Methods of inactivation or attenuation
    • C12N2770/30063—Methods of inactivation or attenuation by chemical treatment
DE602004022139T 2003-02-19 2004-02-18 Expired - Lifetime DE602004022139D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0303867A GB0303867D0 (en) 2003-02-19 2003-02-19 Organic compounds
GB0320195A GB0320195D0 (en) 2003-08-28 2003-08-28 Organic compounds
PCT/EP2004/001543 WO2004074467A1 (en) 2003-02-19 2004-02-18 Inactivated nodavirus vaccine

Publications (1)

Publication Number Publication Date
DE602004022139D1 true DE602004022139D1 (de) 2009-09-03

Family

ID=32910468

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022139T Expired - Lifetime DE602004022139D1 (de) 2003-02-19 2004-02-18

Country Status (18)

Country Link
US (2) US20060257425A1 (de)
EP (1) EP1597359B1 (de)
JP (1) JP4664901B2 (de)
AT (1) ATE437224T1 (de)
AU (1) AU2004213566B2 (de)
CA (1) CA2512930C (de)
CL (1) CL2004000282A1 (de)
CY (1) CY1109344T1 (de)
DE (1) DE602004022139D1 (de)
DK (1) DK1597359T3 (de)
ES (1) ES2328141T3 (de)
HK (1) HK1085765A1 (de)
MY (1) MY143785A (de)
NO (1) NO336878B1 (de)
PT (1) PT1597359E (de)
SI (1) SI1597359T1 (de)
TW (1) TWI347364B (de)
WO (1) WO2004074467A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003262A1 (es) * 2007-11-02 2009-06-26 Intervet Int Bv Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.
KR101608121B1 (ko) * 2012-09-20 2016-04-01 중앙대학교 산학협력단 노다바이러스의 바이러스 유사입자의 생산방법, 이를 발현하는 효모 세포주 및 이를 포함하는 백신 조성물
KR101414009B1 (ko) * 2012-11-16 2014-07-02 주식회사 젠닥스 형질전환 식물체를 이용한 어류 바이러스성 신경괴사증 예방 경구백신 제조방법과 그에 따른 식물체
CN105431168A (zh) * 2013-05-28 2016-03-23 瑞士诺华动物保健有限公司 β诺达病毒在感染中的相互作用
JP2019511208A (ja) 2016-02-02 2019-04-25 ベンチマーク アニマル ヘルス リミテッド ウイルスを作製する方法
CN113429338B (zh) * 2021-05-20 2023-05-02 陕西泰合利华工业有限公司 一种合成氟吡菌酰胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891705A (en) * 1997-04-08 1999-04-06 Pentose Pharmaceuticals, Inc. Method for inactivating a virus
AU3353599A (en) * 1998-03-31 1999-10-18 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
US20040001863A1 (en) * 1998-12-03 2004-01-01 Shau-Chi Chi Immortal cell line derived from grouper Epinephelus coioides and its applications therein
JP2001161355A (ja) * 1999-11-25 2001-06-19 Natl Sci Council ハタ科チャイロマルハタから得られる不死の細胞株およびその応用
AU2002233969A1 (en) * 2001-12-07 2003-06-23 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US20050118194A1 (en) * 2003-12-01 2005-06-02 Sin Yoke M. Oral vaccine, method for its preparation and use thereof

Also Published As

Publication number Publication date
US8124100B2 (en) 2012-02-28
DK1597359T3 (da) 2009-11-16
MY143785A (en) 2011-07-15
ATE437224T1 (de) 2009-08-15
NO20054219L (no) 2005-09-12
US20090288179A1 (en) 2009-11-19
US20060257425A1 (en) 2006-11-16
CA2512930C (en) 2015-06-02
JP2006517943A (ja) 2006-08-03
TW200425899A (en) 2004-12-01
CY1109344T1 (el) 2014-07-02
NO336878B1 (no) 2015-11-23
PT1597359E (pt) 2009-08-06
EP1597359B1 (de) 2009-07-22
CA2512930A1 (en) 2004-09-02
TWI347364B (en) 2011-08-21
NO20054219D0 (no) 2005-09-12
SI1597359T1 (sl) 2009-12-31
CL2004000282A1 (es) 2005-03-28
JP4664901B2 (ja) 2011-04-06
AU2004213566B2 (en) 2007-08-23
EP1597359A1 (de) 2005-11-23
WO2004074467A1 (en) 2004-09-02
HK1085765A1 (en) 2006-09-01
AU2004213566A1 (en) 2004-09-02
ES2328141T3 (es) 2009-11-10

Similar Documents

Publication Publication Date Title
CY1109344T1 (el) Εμβολιο αδρανοποιημενου nodavirus
EA200501689A1 (ru) Соединения в качестве ингибиторов вируса гепатита c
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
GEP20063938B (en) Hepatitis c virus inhibitors
ATE542826T1 (de) Inhibitoren des hepatitis-c-virus
EA200701669A1 (ru) Композиции и способы лечения или предотвращения инфекций, вызванных вирусами семейства flaviviridae
NO20062146L (no) Nukleosidforbindelser for behandling av virusinfeksjoner
NO20070751L (no) Inhibitorer av HCV-replifikasjon
UY28525A1 (es) Péptidos macrociclicos activos contra en virus de la hepatitis c
HK1082737A1 (en) Triheterocyclic compounds, compositions, and methods for treating cancer
UY28758A1 (es) Inhibidores de polimerasa viral
AR061008A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo
AR043929A1 (es) Fases cristalinas de un inhibidor del hcv
MX2007000356A (es) Nuevos usos.
NO20034878L (no) Antivirale forbindelser
EA201270275A1 (ru) Кристаллическое соединение пиридазина
ATE455124T1 (de) Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
WO2007035530A3 (en) Ancestral dengue virus envelope protein sequence
ATE359815T1 (de) Streptococcus-phocae-vakzine
DE60224026D1 (de) Rechen
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
TW200614989A (en) Inhibitors of HCV replication
RU2005114708A (ru) Способ лечения деформирующего остеоартроза

Legal Events

Date Code Title Description
8364 No opposition during term of opposition